As of 2024-12-13, the Intrinsic Value of Prelude Therapeutics Inc (PRLD) is
-11.95 USD. This PRLD valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.89 USD, the upside of Prelude Therapeutics Inc is
-1,449.68%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-11.95 USD
Intrinsic Value
PRLD Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-11.95 - -11.95 |
-11.95 |
-1,449.68% |
| P/E |
(66.62) - (66.91) |
(64.99) |
-7442.3% |
| DDM - Stable |
(13.33) - (29.83) |
(21.58) |
-2537.6% |
| DDM - Multi |
(10.85) - (19.08) |
(13.85) |
-1664.8% |
PRLD Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
48.72 |
| Beta |
0.21 |
| Outstanding shares (mil) |
55.04 |
| Enterprise Value (mil) |
37.95 |
| Market risk premium |
4.60% |
| Cost of Equity |
13.88% |
| Cost of Debt |
5.00% |
| WACC |
8.78% |